This year CSL Behring has granted for the first-time awards for aspiring clinicians and scientists for their clinical and research projects in the field of Alpha 1 Antitrypsin Deficiency (AATD). The purpose of the Alpha1 Science Awards is to benefit the patients suffering from AATD, improving their lives through driving innovations withing the field of AATD and promoting the next generation of AATD specialists addressing patients’ needs.
For the best clinical work Dr. med. Malin Fromme was awarded by our scientific committee. The title of her project is ‘Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency’. She is working as a coordinating study physician at the Alpha1 Liver Center with Prof. Pawl Strnad at the University Hospital in Aachen.
Mr. Srinu Tumpara, M.Sc., received an award from our scientific committee for the best basic scientific work. The title of his project is ‘Polymerization of misfolded Z alpha-1 antitrypsin protein lowers CX3CR1 expression in human PBMCs’. He is working as a research associate in the Molecular Pneumology group from Prof. Sabina Janciauskiene in the Clinic for Pneumology at Hannover Medical School.
Congratulations to the winners! The Award Ceremony of the Alpha1 Science Awards 2022 took place during the CSL Behring Symposium at the DGP congress on May 25th in Leipzig.
Experts of the scientific committee granting Alpha1 Science Awards 2022:
- Prof. Dr. Joachim Ficker, University Clinic of the Paracelsus Med. Private University, Nuremberg
- Prof. Dr. Rembert Koczulla, Schön Clinic Berchtesgadener Land, Schönau
- Prof. Dr. Winfried Randerath, Hospital Bethanien gGmbH, Solingen
- Prof. Dr. Daiana Stolz, University Hospital Freiburg
- Prof. Dr. Claus Vogelmeier, University Hospital Marburg
